{
    "schema": 1,
    "fid": "new-tb-risk-data-raises-bar-glp-1-sourcing",
    "type": "article",
    "object_id": 796,
    "title": "New TB risk data raises the bar on your GLP-1 sourcing",
    "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
    "url": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing",
    "facts_url": "https://www.preppinpeppers.com/facts/new-tb-risk-data-raises-bar-glp-1-sourcing",
    "currency": null,
    "tldr": "New observational data links GLP-1 receptor agonists to fewer tuberculosis diagnoses in type 2 diabetes. Why sourcing and endotoxin control matter in the lab.",
    "facts": [
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:title",
            "category": "identity",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "title",
            "value": "New TB risk data raises the bar on your GLP-1 sourcing",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:published",
            "category": "identity",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "published",
            "value": "2026-08-22",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:author",
            "category": "identity",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "author",
            "value": "PreppinPeppers Editorial Team",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:topics",
            "category": "identity",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "topics",
            "value": "News, peptide news, research news",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:summary",
            "category": "content",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "summary",
            "value": "New observational data links GLP-1 receptor agonists to fewer tuberculosis diagnoses in type 2 diabetes. Why sourcing and endotoxin control matter in the lab.",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:section-1",
            "category": "content",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "section",
            "value": "What they are",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:section-2",
            "category": "content",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "section",
            "value": "What the finding actually covers",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:section-3",
            "category": "content",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "section",
            "value": "Not every GLP-1 compound is the same molecule",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:section-4",
            "category": "content",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "section",
            "value": "Where the research community gets this wrong",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:source-bioengineer-org",
            "category": "source",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "cites",
            "value": "this coverage at Bioengineer.org → - bioengineer.org",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://bioengineer.org/glp-1-drugs-and-tuberculosis-risk-in-people-with-type-2-diabetes/"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:source-pmc-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "cites",
            "value": "Liao et al., Nat Commun 2026: Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13594082/"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:product-gansulin-metal-peptide-pen",
            "category": "products",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "references product",
            "value": "Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-metal-peptide-pen"
        },
        {
            "id": "new-tb-risk-data-raises-bar-glp-1-sourcing:product-gansulin-3ml-cartridge",
            "category": "products",
            "entity": "New TB risk data raises the bar on your GLP-1 sourcing",
            "attribute": "references product",
            "value": "Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-3ml-cartridge"
        }
    ],
    "buy": [],
    "faq": [
        {
            "q": "Do GLP-1 receptor agonists lower tuberculosis risk?",
            "a": "An observational analysis found fewer TB diagnoses among people with type 2 diabetes using GLP-1 receptor agonists versus other diabetes drugs, but this is an association, not proof the peptide directly blocks infection."
        },
        {
            "q": "Why does diabetes raise tuberculosis risk?",
            "a": "Long-term high blood sugar weakens macrophages, the immune cells that normally surround and destroy the TB bacterium, making infection more likely to take hold and progress."
        },
        {
            "q": "Are semaglutide, tirzepatide, and retatrutide the same class of compound?",
            "a": "No. Semaglutide targets only the GLP-1 receptor, tirzepatide targets GLP-1 and GIP receptors, and retatrutide targets GLP-1, GIP, and glucagon receptors, so effects aren't interchangeable in research."
        }
    ],
    "jsonld": [
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "headline": "New TB risk data raises the bar on your GLP-1 sourcing",
            "url": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing",
            "mainEntityOfPage": "https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing",
            "datePublished": "2026-08-22",
            "dateModified": "2026-10-16",
            "author": {
                "@type": "Person",
                "name": "PreppinPeppers Editorial Team"
            },
            "publisher": {
                "@type": "Organization",
                "name": "PreppinPeppers"
            },
            "description": "New observational data links GLP-1 receptor agonists to fewer tuberculosis diagnoses in type 2 diabetes. Why sourcing and endotoxin control matter in the lab."
        },
        {
            "@context": "https://schema.org",
            "@type": "FAQPage",
            "url": "https://www.preppinpeppers.com/facts/new-tb-risk-data-raises-bar-glp-1-sourcing",
            "mainEntity": [
                {
                    "@type": "Question",
                    "name": "Do GLP-1 receptor agonists lower tuberculosis risk?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "An observational analysis found fewer TB diagnoses among people with type 2 diabetes using GLP-1 receptor agonists versus other diabetes drugs, but this is an association, not proof the peptide directly blocks infection."
                    }
                },
                {
                    "@type": "Question",
                    "name": "Why does diabetes raise tuberculosis risk?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Long-term high blood sugar weakens macrophages, the immune cells that normally surround and destroy the TB bacterium, making infection more likely to take hold and progress."
                    }
                },
                {
                    "@type": "Question",
                    "name": "Are semaglutide, tirzepatide, and retatrutide the same class of compound?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "No. Semaglutide targets only the GLP-1 receptor, tirzepatide targets GLP-1 and GIP receptors, and retatrutide targets GLP-1, GIP, and glucagon receptors, so effects aren't interchangeable in research."
                    }
                }
            ]
        }
    ],
    "dates": {
        "published": "2026-08-22",
        "modified": "2026-10-16"
    }
}